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Abstract
Background: We previously observed that allergen-exposed mice exhibit remodeling of large
bronchial-associated blood vessels. The aim of the study was to examine whether vascular
remodeling occurs also in vessels where a spill-over effect of bronchial remodeling molecules is less
likely.
Methods: We used an established mouse model of allergic airway inflammation, where an allergic
airway inflammation is triggered by inhalations of OVA. Remodeling of bronchial un-associated
vessels was determined histologically by staining for α-smooth muscle actin, procollagen I, Ki67 and
von Willebrand-factor. Myofibroblasts were defined as and visualized by double staining for α-
smooth muscle actin and procollagen I. For quantification the blood vessels were divided, based on
length of basement membrane, into groups; small (≤250 μm) and mid-sized (250–500 μm).
Results: We discovered marked remodeling in solitary small and mid-sized blood vessels. Smooth
muscle mass increased significantly as did the number of proliferating smooth muscle and
endothelial cells. The changes were similar to those previously seen in large bronchial-associated
vessels. Additionally, normally poorly muscularized blood vessels changed phenotype to a more
muscularized type and the number of myofibroblasts around the small and mid-sized vessels
increased following allergen challenge.
Conclusion:  We demonstrate that allergic airway inflammation in mice is accompanied by
remodeling of small and mid-sized pulmonary blood vessels some distance away (at least 150 μm)
from the allergen-exposed bronchi. The present findings suggest the possibility that allergic airway
inflammation may cause such vascular remodeling as previously associated with lung inflammatory
conditions involving a risk for development of pulmonary hypertension.
Background
Allergic airway inflammation is known to be associated
with persistent inflammation and tissue remodeling, such
as subepithelial fibrosis, smooth muscle thickening and
increased vascularity in the bronchial circulation [1-3].
Most of our knowledge of remodeling in asthma ema-
nates from studies of bronchial biopsies involving the
large airways. However, asthma is not only a large airway
disease, but also affects other parts of the lung, notably the
small airways and possibly the bronchial-associated
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blood vessels [4,5]. Partly in agreement with findings in
severe asthma [5] we have previously shown [6] that large
blood vessels adjacent to mouse allergen-exposed bronchi
are inflamed and exhibit vascular remodeling, a feature
recently also described in asthma [7].
In the current literature there are only a few descriptions
of pulmonary vascular remodeling following allergic air-
way inflammation. By contrast, remodeling of these ves-
sels is an accepted feature of several other diseases such as
systemic scleroderma [8], idiopathic pulmonary fibrosis
[9] and COPD [10,11]. The mechanism behind vascular
remodeling may vary with disease, but the histological
appearances appear to be similar in nature [12]. In a pre-
vious paper [6], we reported that remodeling of the large
pulmonary vessels was as prominent as the bronchial
remodeling in a mouse model of airway allergic inflam-
mation. For example, similar increases in smooth muscle
mass, collagen synthesis and proliferation occurred in
both airways and adjacent large vessels, a phenomenon
tentatively explained by a spill-over of inflammatory
mediators released in the adjacent bronchial tissues.
Here we report that vascular remodeling changes are also
present in smaller extra-bronchial (pulmonary) solitary
vessels, and include the occurrence of phenotypic changes
in partially muscularized blood vessels and appearance of
perivascular myofibroblasts.
Methods
Model of allergic inflammation
Female BALB/C mice (15–20 grams, MoB A/S, Ry, Den-
mark) were sensitized day 0 with ovalbumin (n = 10, 10
μg OVA (grade III, Sigma, St Louis, MO) + 1 mg AlOH3
i.p.) or saline (n = 7), followed by daily 30 min 1% OVA
aerosol exposures days 14–20, according to a validated
protocol [13]. Day 21 the animals were sacrificed and
lung tissue specimens were processed for cryostat (eosi-
nophil-staining) and paraffin sectioning (IHC- and
TUNEL-staining) [13]. For all immunohistochemical
staining a standard protocol was used, as previously
described [6]. Briefly antibody was applied onto the sec-
tion in appropriate dilution, incubated over night in 4°C,
washed the next day and incubated with secondary anti-
body (45 minutes in room temperature). All animal pro-
tocols were approved by the local ethics committee
(Malmö/Lund, Sweden).
Tissue eosinophilia and cell turnover
The presence of an allergic airway inflammation was
determined as lung tissue eosinophilia, (enzyme-histo-
chemical staining for eosinophil peroxidase, EPO [14]).
Proliferation was detected by immunohistochemical
staining for the proliferation antigen PCNA (U7032,
Dako A/S, Glostrup, Denmark). Apoptosis was detected
by TUNEL technique, as previously described [15], and
visualized by an anti-DIG antibody combined with New
Fuchsine (D5105 and K698, both Dako). Eosinophilia
and cell turnover was quantified in digital images as
labelled cells/area (mm2).
Remodeling
An antibody against α-smooth muscle actin (α-SMA,
1:300, clone 1A4, Sigma) was used to visualize smooth
muscle cells (SMC). Collagen synthesis was assessed by
staining for procollagen I (as previously described [6],
PINP, 1:200, a kind gift from Professor Juha Risteli, Oulo
University, Oulo, Finland). Myofibroblasts were defined
as solitary cells co-positive for procollagen I and α-SMA.
An anti-von Willebrand factor antibody was used to visu-
alize endothelial cells (1:640, A0082, Dako). Proliferating
SMC and endothelial cells were visualized by double-
staining with the proliferation marker Ki67 (M7249,
1:200, clone TEC-3, Dako).
Quantification and statistics
Histologic analysis was preformed as previously described
[6]. Briefly, high-resolution digital images (3 images per
section) were obtained in a random fashion. Transversally
cut blood vessels within the sections (excluding any bron-
chial-associated vessels) were analyzed after being divided
into subgroups depending on size into small (≤250 μm in
perimeter) and mid-sized (250–500 μm in perimeter) ves-
sels. All vessels were non-bronchial associated (solitary),
defined as being ≤150  μm distant from any bronchi.
Quantification was done as previously described [6],
briefly the length of the vascular basement membrane
(BM) was assessed by manual cursor tracing and the
labelled area/number of cells was quantified and corre-
lated to the length of the BM. All quantifications were
made in a blinded fashion, and the Wilcoxon Signed-
ranks test was used for statistical analysis (Analyze It™,
Analyze-it Software Ltd, Leeds, UK). Data are given as
mean values ± SEM, and p < 0.05 was considered statisti-
cally significant.
Results
Eosinophilia and cell turnover
Seven days of allergen exposure initiated a prominent
eosinophilia, with both perivascular and peribronchial
distribution. The total number of eosinophils in sections
were significantly increased in allergen exposed animals
(231 ± 42 cells/mm2) compared to controls (63 ± 31 cells/
mm2, p < 0.05). Notably, perivascular eosinophilia was
present around both small and mid-sized solitary blood
vessels. The overall cell turnover in lungs increased fol-
lowing allergen exposure, both the number of proliferat-
ing and apoptotic cells increased significantly. The
number of proliferating cells increased from 2.9 ± 0.6
cells/mm2 in controls to 18.7 ± 2.8 cells/mm2 followingRespiratory Research 2008, 9:18 http://respiratory-research.com/content/9/1/18
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allergen challenge (p < 0.05), whereas the number of
apoptotic cells increased from 12 ± 2.4 cells/mm2 in con-
trols to 26 ± 5.7 (p < 0.05).
Endothelial cell turnover following allergen exposure
The number of proliferating endothelial cells in mid-sized
blood vessels increased significantly in response to aller-
gen (Figure 1), and the number of proliferating endothe-
lial cells in small vessels displayed a similar increase
(Figure 1). The apparent lack of proliferating cells in con-
trols is somewhat misleading, as proliferating cells was
seen in controls. However the baseline proliferation was
very low and correlation to the length of the BM results in
a very low value. No increase of the number of apoptotic
endothelial cells was detected in either mid-sized or small
blood vessels following allergen exposure (data not
shown).
Vascular smooth muscle remodeling
The perivascular smooth muscle area of mid-sized vessels
was significantly increased in animals exposed to allergen
(Figures 2 and 3). The increase was at least partially due to
hyperplasia, since the number of proliferating smooth
muscle cells also increased (1.7 ± 0.6 in controls to 10.8 ±
0.6 cells/mm in allergen exposed animals (p < 0.01)),
whereas the number of apoptotic smooth muscle cells did
not change (data not shown). Small blood vessels dis-
played again a similar increase as the mid-sized; the
perivascular smooth muscle area increased significantly
following allergen exposure (Figures 2 and 3), and thus
causing muscularization of partially muscularized blood
vessels. The number of proliferating smooth muscle cells
was significantly increased in animals exposed to allergen,
increasing from 0.1 ± 0.4 cells/mm in controls to 11 ± 0.9
in allergen exposed animals (p < 0.01), the number of
apoptotic cells did not change (data not shown).
Alteration of collagen synthesis
In sections from allergen exposed animals, the number of
procollagen I-positive cells increased significantly around
middle-sized blood vessels (p < 0.05), from 1 ± 0.4 in con-
trols to 4.1 ± 0.4 cells/mm in allergen exposed animals. A
similar increase was detected in the number of myofi-
broblasts, defined by co-positive for α-SMA and procolla-
gen I (Figures 3 and 4). In contrast to middle-sized blood
vessels, no significant increase in the number of procolla-
gen I-positive cells around small blood vessels was found.
Nevertheless, the number of myofibroblasts was signifi-
cantly increased around small blood vessels (Figures 3
and 4).
Discussion
The present study demonstrates remodeling in small to
mid-sized solitary vessels in the lungs of allergic mice
challenged intra-bronchially with allergen. The remode-
ling characteristics observed in this study were similar to
changes previously described in large bronchial-associ-
ated vessels [6], with a few exceptions. We thus made the
additional observation here that small, previously poorly
or partially muscularized blood vessels transformed to a
more muscularized phenotype (increased perivascular
smooth muscle mass), accompanied by the appearance of
myofibroblasts. The increased number of proliferating
SMC was similar in the large and mid-sized blood vessels
Smooth muscle mass increase in both small and mid-sized  blood vessels following allergen challenge Figure 2
Smooth muscle mass increase in both small and mid-
sized blood vessels following allergen challenge. The 
area of vascular smooth muscle increased after allergen 
exposure, in small vessels approximately 5 times and in mid-
sized approximately 3 times. Smooth muscle was detected by 
labelling with α-smooth muscle actin, and the positively 
stained area measured by digital image analysis and corre-
lated to the length of the basement membrane (BM). The 
data are given as mean ± SEM and compared against control 
using the Wilcoxon Signed-ranks test, * indicates p < 0.05.
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Endothelial proliferation increased following allergic airway  inflammation Figure 1
Endothelial proliferation increased following allergic 
airway inflammation. The number of proliferating 
endothelial cells in small and mid-sized blood vessels 
increased following allergen challenge. Proliferation was 
detected using the proliferation-marker Ki67. A base line 
proliferation was present also in controls, however the 
number was very low and when correlated to the length of 
the basement membrane (BM), the values closed in on zero. 
The data are given as mean ± SEM and compared against 
control using the Wilcoxon Signed-ranks test, * indicates p < 
0.05.
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but greatly enhanced in small vessels. In contrast, the
number of procollagen I producing cells was not
increased in small vessels, yet increased in mid-sized (this
study) and large vessels (5). Taken together our results
suggest that allergic airway inflammation in mice involves
size-dependent remodeling features in lung blood vessels
irrespective of how close these vessels are to the allergen-
exposed bronchi. The mean inner diameter of small soli-
tary vessels displayed a slight reduction in allergen-
exposed animals, whereas the external diameter did not
change (data not shown). This alteration cannot be com-
pletely ruled out as an artefact; however the a more likely
explanation is that increased smooth muscle reacts more
strongly to the sacrificial procedure and thus decrease the
diameter more than controls. This would be in accordance
with the findings of Witzenrath [16], who found vessels
from OVA-sensitized and -challenged mice to be hyper
reactive.
The vessels were divided into subgroups depending on
size and localization, due to practical reasons; the small
solitary vessels (microvessels) were very difficult to exactly
differentiate into arterioles or venules. Larger vessels can
however be classified; the criteria is primarily based on
localization and the presence of elastic lamina(s) and we
have not been able to find a definition applicable for
mice. Nevertheless, due to these criteria the "mid-sized
solitary vessels" is defined as (post-capillary) veins and
since they are located within the lung parenchyma they
are most likely pre-septal veins. The vessels described in
the previous study [6] is by this definition pulmonary
arteries. Our results thus suggest that vascular remodeling
occurs in both pre- and post-capillary vessels, as well as in
the microvessels.
Exactly how the vascular remodeling is induced is not
known; it has been speculated that lung vascular remode-
ling is induced by "spill over" of inflammatory mediators
from the bronchi [5]. However, the present results, dem-
onstrating marked remodeling effects in more remote pul-
monary vessels some distance away (at least 150 μm)
from the bronchi, may not support this notion. Thus the
link between allergic bronchial processes and pulmonary
vascular inflammation and remodeling remains elusive.
Since the OVA used in the study is not endotoxin free, it
cannot be ruled out that the vascular remodeling is caused
by the endotoxin (alone or in combination with OVA),
although this seems unlikely as studies utilizing sham-
sensitized OVA-challenged animals, find no airway
inflammation. More interestingly, it has recently been
reported that chymase-positive mast cells are involved in
the remodeling of the bronchial circulation of asthmatics
[17]. The importance of eosinophils in the development
of bronchial remodeling has also been highlighted
recently [18], and future studies will have to show
Significant increase in myofibroblasts numbers following aller- gen challenge Figure 4
Significant increase in myofibroblasts numbers fol-
lowing allergen challenge. The number of myofibroblasts 
(defined as solitary cells co-positive for α-smooth muscle 
actin and procollagen I) increased significantly following aller-
gen exposure. Occasional smooth muscle cells may produce 
procollagen I; however smooth muscle cells are not normally 
solitary. Sporadic myofibroblasts were also visible before 
allergen challenge, but when correlated to the length of the 
basement membrane (BM) the values are very small and 
closed in on zero. The data are given as mean ± SEM and 
compared against control using the Wilcoxon Signed-ranks 
test, * indicates p < 0.05.
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Photomicrographs illustrating vascular remodeling following  7 days of allergen exposure Figure 3
Photomicrographs illustrating vascular remodeling 
following 7 days of allergen exposure. Vascular remode-
ling involves smooth muscle (α-smooth muscle actin: red), 
fibroblasts (procollagen I: brown) and myofibroblasts (here 
defined as solitary cells co-positive for α-smooth muscle 
actin and procollagen I: co-positive), in both small solitary (A-
B) and mid-sized solitary (C-D) vessels. In comparison with 
controls (A and C) vessels from OVA exposed animals (B 
and D) show a significantly increased smooth muscle area as 
well as increased number of myofibroblasts (arrows) and 
procollagen I-producing cells. Vascular lumen is indicated by 
stars. Scale bar represents 50 μm.Respiratory Research 2008, 9:18 http://respiratory-research.com/content/9/1/18
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whether similar mechanisms may operate in the pulmo-
nary circulation. Another possible explanation behind the
vascular remodeling includes increased activity of local
fibroblasts. The rather prompt appearance of myofibrob-
lasts following allergen challenge in this study is intrigu-
ing. Furthermore, we observed that some myofibroblasts
were localized between the basement membrane and
smooth muscle layer. Thus we cannot exclude the possi-
bility that migrating and proliferating fibroblasts have
contributed to the present vascular remodeling effects.
Indeed, a difference between cells from OVA-challenged
animals and controls have been established in cultured
fibroblasts, where cells from OVA-challenged animals
demonstrates pro-fibrotic activities[19]. However the
molecular regulation of this latter transformation has not
yet been determined.
Although remodeling of the pulmonary circulation is a
likely cause of pulmonary hypertension [8,9,20], asthma
is not normally associated with pulmonary hypertension.
However, an extensive literature search revealed some
interesting material in this regard; Salako et. al. [21]
reported transient pulmonary hypertension during an
asthma attacks and several papers actually connect asthma
and pulmonary hypertension/cor pulmonale [22-26].
Several of these clinical studies are old representing time
periods when asthma was not as well treated as today.
Today asthmatic inflammation is usually better controlled
by drugs, speculatively reducing also the risk for develop-
ment of serious vascular remodeling. Furthermore, the
pulmonary vasculature exhibits a great dynamic ability to
compensate for structural changes, which may result in
clinical symptoms not showing until later stages of the
disease and then only as very modest increases. This is
indicated by reports of scleroderma patients displaying
vascular remodeling even without clinical symptoms [12].
Also, it is of note that even small increases in the pulmo-
nary pressure in COPD patients is associated with
increased mortality [27]. Furthermore, our results high-
lights the involvement of inflammation in the develop-
ment of pulmonary vascular remodeling, in accordance
with previous publications [28,29], indicating a role of
inflammation in the vascular remodeling associated with
PAH.
It was recently shown that the pulmonary vasculature dis-
plays a hyper-reactive phenotype in response to for exam-
ple serotonin [16], following allergic airway
inflammation in animals. The authors did not speculate
in any clinical implications, but the results suggest a direct
connection between allergic airway inflammation and
physiologic vascular responses in experimental animals.
Tigani and co-workers [30], recently reported that vascular
remodeling also occurs in Brown Norway rats following
OVA-challenge, and similar changes are also present in
asthmatic patients [7]. Based on the current results, we
conclude that lung vascular remodeling is present in sev-
eral animal models of airway inflammation, in both pre-
and post capillary vessels, and potentially causes signifi-
cant physiological effects. Based on the findings by Salako
et. al [21] in asthma, and the likelihood that vascular
remodeling is physiologically important in several other
clinical conditions [8-11,20], we suggest that our findings
may have some clinical relevance. However, it is impor-
tant to recognize that the OVA-model used in this study is
far from being equivalent to human disease [31] although
it can be argued that similarly expressed lung vascular
remodeling occurs in mice and humans.
Conclusion
In summary, we have shown that, in our mouse model of
allergic airway inflammation, vascular remodeling affects
small, mid-sized and large blood vessels. The bronchial
allergen challenges result in classical vascular remodeling
as well as phenotypic changes particularly in the small
pulmonary blood vessels. Our results suggest that allergic
airway inflammation is accompanied by remodeling of
the entire pulmonary circulation potentially increasing
the risk for development of pulmonary hypertension.
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